New hope in Aids war

admin

Anso Thom Health-e News Service South African HIV clinicians have welcomed an announcement that the Food and Drug Administration (FDA) in the US has approved the use of an antiretroviral drug by sexually-active HIV-negative men and women as a way of reducing the risk of HIV infection in adults. The debate around the use of ARVs as prevention surfaced several years ago with a number of studies showing it to be effective and safe. In what has been described as possibly a major turning point, the FDA announced this week that it had approved the use of tenofovir disoproxil fumarate/ emtricitabine (TDF/FTC), also known as Truvada, in HIV prevention. TDF/FTC has been used to treat HIV infection…

Next Post

Twickenham Studios saved for film

Twickenham Film Studios is saved after its new owner promised to continue making films at the site.